Bio Rad Laboratories Inc (NYSE:BIO)
| 375.34 Delayed Data As of Jan 23 |  -3.18 / -0.84%Today’s Change | 233.18 Today|||52-Week Range 391.22 | +1.44% Year-to-Date |
Latest BIO News | Press Releases
No recent news for Bio Rad Laboratories Inc.
Today’s Trading
| Previous close | 378.52 |
| Today’s open | 377.11 |
| Day’s range | 375.28 - 379.34 |
| Volume | 166,592 |
| Average volume (3 months) | 226,469 |
| Market cap | $9.4B |
Data as of 6:30pm ET, 01/23/2020
Growth & Valuation
| Earnings growth (last year) | +197.26% |
| Earnings growth (this year) | +23.47% |
| Earnings growth (next 5 years) | +18.88% |
| Revenue growth (last year) | +5.98% |
| P/E ratio | 29.9 |
| Price/Sales | 3.07 |
| Price/Book | 2.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | -0.37 | -0.70% |
| QGENQiagen NV | -0.01 | -0.03% |
| PKIPerkinElmer Inc | -1.43 | -1.42% |
| WATWaters Corp | -2.16 | -0.88% |
Data as of 6:30pm ET, 01/23/2020
Financials
| Next reporting date | February 27, 2020 |
| EPS forecast (this quarter) | $2.45 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $365.6M |
| Net profit margin | 15.97% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
